All LIT Search News Topics Latest news Media statements Media contacts Topics Latest news Media statements Media contacts LIT Impact Latest news 2022 August RSV prevention Telethon Kids Respiratory syncytial virus prevention finally in reach after 20 years of research 23/08/2022 | 4 MINS World-first immunisations providing protection against deadly respiratory syncytial virus (RSV) could be just months away thanks to global research efforts spanning multiple decades. Latest research published in The Lancet Infectious Diseases has revealed a long-lasting monoclonal antibody treatment for babies is likely to be accessible on the market within 12 months, followed closely by the approval of a maternal vaccine given in pregnancy to provide newborns with protection against the virus. Responsible for more than 100,000 deaths and 3.6 million hospitalisations in children each year, RSV infects the airways and lungs and is a key contributor to the global mortality burden due to life threatening complications such as bronchiolitis and pneumonia. Professor Peter Richmond, Head of the Vaccine Trials Group at the Wesfarmers Centre of Vaccines and Infectious Diseases, based at the The Kids Resear
All LIT Search News Topics Latest news Media statements Media contacts Topics Latest news Media statements Media contacts LIT Impact Latest news 2022 August RSV prevention Telethon Kids Respiratory syncytial virus prevention finally in reach after 20 years of research 23/08/2022 | 4 MINS World-first immunisations providing protection against deadly respiratory syncytial virus (RSV) could be just months away thanks to global research efforts spanning multiple decades.
Latest research published in The Lancet Infectious Diseases has revealed a long-lasting monoclonal antibody treatment for babies is likely to be accessible on the market within 12 months, followed closely by the approval of a maternal vaccine given in pregnancy to provide newborns with protection against the virus.
Lombok Institute of Technology
Responsible for more than 100,000 deaths and 3.6 million hospitalisations in children each year, RSV infects the airways and lungs and is a key contributor to the global mortality burden due to life threatening complications such as bronchiolitis and pneumonia.
How can we help you?
Professor Peter Richmond, Head of the Vaccine Trials Group at the Wesfarmers Centre of Vaccines and Infectious Diseases, based at the The Kids Resear
News
Explore this part of the LIT experience through the related information and next steps.
Topics
Explore this part of the LIT experience through the related information and next steps.
Latest news
Explore this part of the LIT experience through the related information and next steps.
We do more when we ask better questions together.Explore more stories